News and events

Context
The Multiplier Event was organized within the framework of the Young Endoscopic Gynecologists Conference.

The main topic of the CONSCIOUS II project, which is focused on clinical trials, was closely aligned with the subjects presented at the conference.

Attendance and participation
Attendance (domestic):
- The number of attendees was higher than expected. Several healthcare sectors from Hungary were represented.
International participation:
- A significant number of attendees came from abroad.
Translation services:
- Translation was provided for attendees from different linguistic backgrounds.

Presentation agenda
- Introduction of the CONSCIOUS II Project by Prof. Dr. Gabor L. Kovacs
- Presentation of the reached project results so far
- Q&A Session
- Feedback and closing remarks

Key points discussed
Introduction by Prof. Dr. Gabor L. Kovacs
Prof. Dr. Gabor L. Kovacs took the stage to introduce the CONSCIOUS II project. He began by outlining the project's core objectives and how it aligns with the broader scope of clinical trials in the medical, science, pharmacy, and health professions. With the backdrop of the project's main data displayed on the screen, Prof. Kovacs elaborated on the significance of equipping the next generation of PhD students and early career researchers with the requisite knowledge and skills. The introduction set the stage for a deeper dive into the project's results, providing a comprehensive context for all attendees.

Presentation of reached project results
Following the introductory remarks, Prof. Dr. Gabor L. Kovacs proceeded to present the specific results that the CONSCIOUS II project has reached so far. He highlighted that multiple topics have already been developed and reviewed by experts (ECRIN) in the field. The audience was particularly drawn into the discussion as he delved into the intricacies of the following specialized areas:
- Clinical trials design: Explained how the project has developed comprehensive guidelines and methodologies for designing clinical trials.
- Trial methodology: Discussed the standardized approaches that have been established for conducting trials, making special note of the project's contributions to innovation in this area.
- Trial management: Covered how the project has formulated best practices for the administrative aspects of managing trials.
- Quality and regulatory affairs and sources of regulatory information: Emphasized the importance of maintaining high-quality standards and briefed the audience on the project's repository of regulatory information.
- Pharmacovigilance and study medication: Spoke about the mechanisms in place for monitoring drug safety and the administration of study medications.
- Data management and statistical analysis: Explored how the project has developed robust systems for handling trial data and performing statistical analyses.
- Early phase trials: Gave an overview of how the project is aiding in the planning and implementation of early-phase clinical trials.
- Pediatric clinical trials: Highlighted the project's specialized focus on trials involving pediatric populations.
- Medical devices: Provided insights into the project's work regarding clinical trials for medical devices.
One of the cornerstone of the presentation was the announcement that the joint project website is continuously updated. Prof. Kovacs showcased the website, pointing out its user-friendly interface and the wealth of information it offers. He emphasized that the website serves as a central repository together with joint E-platform for all these developed topics and will continue to be updated as the project progresses.
The detailed exposition of these specialized topics garnered considerable attention from the audience, who appeared visibly impressed by the scope and depth of the project's achievements.

Q&A session
After the presentation, the floor was opened for a question-and-answer session. The audience, clearly impressed by the project's scope and achievements, actively participated. Several pertinent questions were raised, including inquiries about how to access the project's final results once it concludes. Others were keen to know about the logistics of attending the developed courses and any prerequisites for enrollment. Additionally, questions were raised concerning the availability of the course to different sectors of the medical community. Prof. Kovacs and the team took note of these questions, promising to address them in the project's next phases and updates.

Feedback and closing remarks
The event drew to a close with a feedback session that underscored the overwhelmingly positive responses from the audience. The Multiplier Event evidently met, and perhaps even exceeded, its objectives of disseminating information and engaging stakeholders. Prof. Kovacs concluded by expressing gratitude towards the attendees for their active participation and insightful questions. He emphasized that the feedback would be invaluable in shaping the project’s future directions and reiterated the team's commitment to making the course and project results accessible to a broader audience.

The overarching sentiment was that the Multiplier Event was a resounding success. The high attendance, including a notable number of international participants, underscored the project's relevance and the importance of its timely dissemination. The provision of translation services ensured that the event was inclusive and could cater to the linguistic diversity of the attendees, thereby amplifying the project's impact.